Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Department's Website: https://engineering.uark.edu/ Summary of Job Duties: The Postdoctoral Research Associate - Biomedical Engineering will test commercially available membranes and develop novel membranes
-
genotyping several transgenic lines with minimal to no error). As instructed, performs intracranial stereotaxic injection of viral vectors followed by locomotor behavioral analysis (this includes
-
The University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 3 months ago
research interest is to develop adeno-associated virus (AAV) vectors to treat various diseases such as neurodegeneration disorders and liver diseases using animal and other research models, and to study the
-
(recombinant viral vectors – AAV, mouse breeding), imaging (histology, light microscopy, confocal microscopy), and strength analyses (whole body plethysmography to evaluate respiration, limb function tests
-
apply engineering biology and AI approaches to significantly accelerate the optimisation of the cell line development (CLD) processes for next-gen antibodies, focusing on optimising vector design to
-
(viral vector and/or extracellular vesicle-based) for myocardial regeneration. Key project goals are to develop and to deploy novel gene/cell-based therapeutics to restore cell-specific expressions
-
equivalencies: https://hr.uky.edu/employment/working-uk/equivalencies Required Related Experience No experience required. Required License/Registration/Certification KY Radiation Operator’s License at time of
-
information about equivalencies: https://hr.uky.edu/employment/working-uk/equivalencies Required Related Experience No experience required. Required License/Registration/Certification KY Radiation Operator’s
-
, KY Grade Level 09 Salary Range $21.00-34.29/hour Type of Position Staff Position Time Status Full-Time Required Education HS Click here for more information about equivalencies: https://hr.uky.edu
-
activation, cytotoxicity, and persistence. Additional methods may involve CRISPR-based perturbations, viral vector engineering, and immune cell manufacturing workflows relevant to CAR-based therapies. In vivo